CCL8 and COVID-19: In conclusion, our study demonstrates that BLC/CXCL13, sCD30, MCP-2/CCL8 and IP-10/CXCL10 are specifically and individually upregulated in symptomatic COVID-19-positive patients but not in patients suffering from other respiratory infections with similar symptoms.